previous compound ID: 279 next compound
InChIKey: BSJMWHQBCZFXBR-UHFFFAOYSA-N
SMILES: C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"JW Hanrahan" "R Robert" "J Liao" "J Goepp" "SD Macknight" "B Kus" "DY Thomas" "GW Carlile" "D Rotin" "E Matthes"

chemical graph of compound 279





CID is 74989
synonyms found at PubChem are:
ATOVAQUONE, 95233-18-4, Mepron, Wellvone, Acuvel, 566C80, Mepron (antipneumocystic), Atavaquone, Malarone Pediatric, BW 566C, 566C, Atovaquone (Atavaquone), cis-Atovaquone, DRG-0084, 94015-53-9, UNII-Y883P1Z2LT, C22H19ClO3, Atovaquone [USAN:BAN:INN], BW 566C-80, Mepron (TN), BW-A 566C, HSDB 7083, 2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, BW-566C-80, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone, CRL-8131 & Atovaquone, Atovaquone & Interleukin 12, Y883P1Z2LT, ATO & IL-12, BW-566C, CHEBI:575568, KUCQYCKVKVOKAY-UHFFFAOYSA-N, BW 566C80, 137732-39-9, NCGC00016961-01, 2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione, CAS-95233-18-4, 2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione, DSSTox_CID_2629, trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione, 2-(TRANS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHALENEDIONE, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-dihydronaphthalene-1,4-dione, DSSTox_RID_76664, DSSTox_GSID_22629, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, 2-[trans-4-(p-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone, 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione, 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione, 1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-, trans-, 1,4-Naphthalenedione, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-, 2-((1r,4r)-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione, SR-05000001438, pron, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone, 566C80 hydroxynaphthoquinone, hydroxynaphthoquinone 566C80, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-naphthalene-1,4-dione, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione, hydroxynaphthoquinone, 566C80, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione, Atovaquone [USAN:USP:INN:BAN], ATOVAQUONE-D4, Spectrum_001743, SpecPlus_000686, Atovaquone (USP/INN), AC1L2MZG, Prestwick0_000534, Prestwick1_000534, Prestwick2_000534, Prestwick3_000534, Spectrum2_001665, Spectrum3_000991, Spectrum4_001117, Spectrum5_001382, Atovaquone EP Impurity B, D06ZEE, AC1Q6E9K, SCHEMBL21694, SCHEMBL21695, Atovaquone (JAN/USP/INN), BSPBio_000547, BSPBio_002681, KBioGR_001594, KBioSS_002223, MLS002153863, BIDD:GT0849, DivK1c_006782, SCHEMBL637069, SPECTRUM1504210, SPBio_001849, SPBio_002468, 566C80, hydroxynaphthoquinone, BPBio1_000603, CHEMBL222334, CHEMBL519462, GTPL9695, NAP016, SCHEMBL1542719, SCHEMBL1649508, SCHEMBL9975142, SCHEMBL9975229, atovaquone GlaxoSmithKline brand, Atovaquone, >=98% (HPLC), DTXSID7022629, CHEBI:95346, CTK5H7581, KBio1_001726, KBio2_002223, KBio2_004791, KBio2_007359, KBio3_001901, KUCQYCKVKVOKAY-CTYIDZIISA-N, KUCQYCKVKVOKAY-OTVXOJSOSA-N, MolPort-003-666-542, MolPort-006-167-710, BDBM192009, Glaxo Wellcome brand of atovaquone, HMS1569L09, HMS1922F19, HMS2089M14, HMS2093C10, HMS2096L09, HMS2235N08, HMS3369N09, HMS3651N20, HMS3713L09, Pharmakon1600-01504210, GlaxoSmithKline brand of atovaquone, 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone, BCP09477, KS-00000FO3, Tox21_110714, CCG-39090, FD7252, NSC759582, s3079, STK636160, trans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone, ZINC12504271, AKOS005567953, AKOS015895691, AKOS015961933, Tox21_110714_1, ZINC100017856, ZINC100345537, ZINC116473771, ZINC299873031, AN-6439, BW 556C-80, BW-556C-80, CCG-220534, CS-2702, DB01117, MCULE-7318126574, NSC-759582, NCGC00016961-02, NCGC00016961-03, NCGC00016961-04, NCGC00016961-06, NCGC00016961-07, NCGC00095113-01, NCGC00095113-02, AC-30251, AS-12809, BC208879, HY-13832, SC-15688, SC-21393, SMR001233220, SBI-0052893.P002, AB0012456, AB0107187, AB0211463, KB-270797, LS-178256, TX-010638, AB00513855, FT-0081084, FT-0602868, C06835, D00236, J90007, 78668-EP2307343A1, AB00053222-03, AB00053222_04, AB00053222_05, 233A184, I06-0872, SR-05000001438-1, SR-05000001438-2, SR-05000001438-4, SR-05000001438-5, 2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-nap, Z1541632806, 2-[4-(4-chlorophenyl)cyclohexy]-3-hydroxy-1,4-naphthoquinone, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-napthoquinone, 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1.4-naphthoquinone, 2-Hydroxy-3-[4-(4-chlorophenyl)cyclohexyl]-1,4-naphthoquinone, 3-[4-(p-chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthoquinone, 1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-, 2-[4-(4-chlorophenyl)-cyclohexyl]-3-hydroxy-1,4-naphthoquinone, 2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthoquinone, trans-, 3-[4-(4-Chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthalenedione, Cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone, 1,4-Naphthalenedione, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy, 1,4-naphthalenedione,2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-